Naoki Isogawa

Shinjiku, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Correction to: Performance Evaluation of Interim Analysis in Bioequivalence Studies : Naoki Isogawa.

Correction to: Performance Evaluation of Interim Analysis in Bioequivalence Studies : Naoki Isogawa.

Journal: Therapeutic innovation & regulatory science

Published: June 10, 2024

Performance Evaluation of Interim Analysis in Bioequivalence Studies.

Performance Evaluation of Interim Analysis in Bioequivalence Studies.

Journal: Therapeutic innovation & regulatory science

Published: December 29, 2023

Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety study.

Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety study.

Journal: Pain management

Published: November 17, 2021

Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies.

Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies.

Journal: Pain and therapy

Published: October 20, 2021

Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease.

Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease.

Journal: Digestive diseases and sciences

Published: February 23, 2021

Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?

Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?

Journal: European journal of pain (London, England)

Published: October 07, 2020

Borrowing external information to improve Bayesian confidence propagation neural network.

Borrowing external information to improve Bayesian confidence propagation neural network.

Journal: European journal of clinical pharmacology

Published: October 23, 2019

A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.

A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.

Journal: Therapeutic innovation & regulatory science

Published: August 02, 2019

Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn's disease in Japanese and Korean patients: the OPERA study.

Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn's disease in Japanese and Korean patients: the OPERA study.

Journal: Intestinal research

Published: April 29, 2019

Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis.

Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis.

Journal: Inflammatory intestinal diseases

Published: April 03, 2019

A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.

A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.

Journal: Therapeutic innovation & regulatory science

Published: January 01, 2019

Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies.

Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies.

Journal: Intestinal research

Published: August 10, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026